(Press-News.org) The University of Exeter recently contributed to a major international project to sequence the genome of Emiliania huxleyi, the microscopic plankton species whose chalky skeletons form the iconic white cliffs of Dover. The results of the project are published this week in the journal Nature.
Emiliania huxleyi is one of the most abundant marine phytoplankton species and is a key player in the process of CO2 exchange between the atmosphere and the ocean. In some marine systems 20% of the total carbon is fixed by E. huxleyi. This microscopic alga has influenced the global climate for over 200 million years, so is used as a model system for studying how physical, chemical and biological processes regulate the Earth's systems. The algae form pale chalky cases called coccoliths which during the spring bloom can be seen from space in the seas around the UK. E. huxleyi directly links to climate change through the production of dimethylsulfide (DMS), which induces cloud formation and blocks solar radiation.
Thanks to new technology – next generation DNA sequencing – 13 different isolates were sequenced from around the world, and compared to a complete sequence constructed for E. huxleyi strain CCMP1516. The allowed the team to understand the influences of different environmental conditions on E. huxleyi physiology. The international team found that E. huxleyi possess a higher number of genes than previously published marine phytoplankton genomes, and that most genes were present in multiple copies.
Dr Mark Van Der Giezen from the University of Exeter said: "Using comprehensive analysis to compare different strains of the algae, we demonstrated that E. huxleyi should no longer be considered a single species. Substantial variation in the genome indicates contrasting metabolic composition and supports the idea that E. huxleyi is a species complex."
Comparing patterns, or phylogenetic relationships, in the genomes of the different strains identified three groups which did not relate to geographic origin nor genome size. Further research into the genomes revealed that the E. huxleyi genome includes core regions shared by all samples with some variable elements. Regions with high levels of tandem repeats and low complexity may have allowed rapid evolutionary adaptation over many millions of years, allowing current strains to live in a range of light conditions.
The study of the E. huxleyi genome shows many unexpected features that may be unique or common in microalgae warranting further investigation. For example, metabolic pathways, known previously only in fungi and animals that allow lipid synthesis were found. Using this new insight into an age-old algae, there is future potential for E. huxleyi to be used to synthesise nutritional supplements, biofuels, feedstock and polymer precursors, which may make E. huxleyi a valuable species for cutting-edge biotechnology.
###
Genome sequencing was performed by the US Department of Energy Joint Genome Institute.
About the University of Exeter
The Sunday Times University of the Year 2012-13, the University of Exeter is a Russell Group university and in the top one percent of institutions globally. It combines world-class research with very high levels of student satisfaction. Exeter has over 18,000 students and is ranked 7th in The Sunday Times University Guide, 10th in The Complete University Guide, 10th in the UK in The Times Good University Guide 2012 and 12th in the Guardian University Guide 2014. In the 2008 Research Assessment Exercise (RAE) 90% of the University's research was rated as being at internationally recognised levels and 16 of its 31 subjects are ranked in the top 10, with 27 subjects ranked in the top 20.
The University has invested strategically to deliver more than £350 million worth of new facilities across its campuses in the last few years; including landmark new student services centres - the Forum in Exeter and The Exchange in Cornwall - and world-class new facilities for Biosciences, the Business School and the Environment and Sustainability Institute. It has plans for another £330 million of investment between now and 2016.
http://www.exeter.ac.uk
For further information:
Dr Jo Bowler
University of Exeter Press Office
Office: +44 (0)1392 722062
Mobile: +44(0)7827 309 332
Twitter: @UoE_ScienceNews
j.bowler@exeter.ac.uk
DNA sequencing uncovers secrets of white cliffs of Dover
2013-06-13
ELSE PRESS RELEASES FROM THIS DATE:
UF study finds brain-imaging technique can help diagnose movement disorders
2013-06-13
GAINESVILLE, Fla. — A new University of Florida study suggests a promising brain-imaging technique has the potential to improve diagnoses for the millions of people with movement disorders such as Parkinson's disease.
Utilizing the diffusion tensor imaging technique, as it is known, could allow clinicians to assess people earlier, leading to improved treatment interventions and therapies for patients.
The three-year study looked at 72 patients, each with a clinically defined movement disorder diagnosis. Using a technique called diffusion tensor imaging, the researchers ...
Gene offers an athlete's heart without the exercise
2013-06-13
Researchers at Case Western Reserve University have found that a single gene poses a double threat to disease: Not only does it inhibit the growth and spread of breast tumors, but it also makes hearts healthier.
In 2012, medical school researchers discovered the suppressive effects of the gene HEXIM1 on breast cancer in mouse models. Now they have demonstrated that it also enhances the number and density of blood vessels in the heart – a sure sign of cardiac fitness.
Scientists re-expressed the HEXIM1 gene in the adult mouse heart and found that the hearts grew heavier ...
Study points to role of nervous system in arthritis
2013-06-13
Arthritis is a debilitating disorder affecting one in 10 Canadians, with pain caused by inflammation and damage to joints.
Yet the condition is poorly managed in most patients, since adequate treatments are lacking – and the therapies that do exist to ease arthritis pain often cause serious side effects, particularly when used long-term. Any hope for developing more-effective treatments for arthritis relies on understanding the processes driving this condition.
A new study in the Journal of Neuroscience by researchers at McGill University adds to a growing body of ...
A peptide to protect brain function
2013-06-13
A structure called "the microtubule network" is a crucial part of our nervous system. It acts as a transportation system within nerve cells, carrying essential proteins and enabling cell-to-cell communications. But in neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's, this network breaks down, hindering motor abilities and cognitive function.
Now Prof. Illana Gozes of Tel Aviv University's Sackler Faculty of Medicine has developed a new peptide in her lab, called NAP or Davunetide, that has the capacity to both protect and restore microtubule function. ...
Helping to restore balance after inner ear disorder
2013-06-13
Many disorders of the inner hear which affect both hearing and balance can be hugely debilitating and are currently largely incurable. Cochlear implants have been used for many years to replace lost hearing resulting from inner ear damage. However, to date, there has not been an analogous treatment for balance disorders resulting from inner ear disease. One potential new treatment is an implantable vestibular prosthesis which would directly activate the vestibular nerve by electrical stimulation. This prosthetic treatment is tested in a new study by Christopher Phillips ...
US forest management policy must evolve to meet bioenergy targets
2013-06-13
CHAMPAIGN, Ill. — In order to keep pace with the burgeoning demand for renewable energy, forest management policy in the U.S. must change to address environmental sustainability issues, according to an article by a University of Illinois expert in bioenergy law.
Unless the forestry sector can tailor sustainable forest management policies specifically to forest-to-energy feedstocks, its role in helping the country broaden its energy portfolio – and by extension, meeting ambitious bioenergy targets – may be limited in large part because of uncertainty about whether existing ...
No good substitute for race in college admissions: Research
2013-06-13
COLLEGE PARK, Md. – As the U.S. Supreme Court decides in a case involving racial preferences in higher education admissions (Fisher v. Texas), new University of Maryland-led research finds that socioeconomic diversity is no replacement for a direct consideration of race, as some have suggested. Still the research finds that a mix of students from differing socio-economic backgrounds has benefits.
The peer-reviewed study appears in the June issue of the "American Educational Research Journal." It evaluates the use of "socio-economic status" as a racially blind way to build ...
Yale researchers unravel genetics of dyslexia and language impairment
2013-06-13
A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.
The study is published online and in the July print issue of the American Journal of Human Genetics. Senior author Jeffrey R. Gruen, M.D., professor of pediatrics, genetics, and investigative medicine at Yale, and colleagues analyzed data from more than 10,000 children born ...
Men with restless legs syndrome may be at higher risk of early death
2013-06-13
MINNEAPOLIS – Men who experience restless legs syndrome (RLS) may have a higher risk of dying earlier, according to research that appears in the June 12, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The disorder is characterized by an irresistible urge to move the legs and often causes leg sensations of burning, creeping, and tugging, which are usually worse at night.
"RLS affects five to 10 percent of adults across the country," said study author Xiang Gao, MD, PhD, with Harvard School of Public Health, Harvard Medical School ...
Biomarkers may be key to discovery of successful initial treatment of depression
2013-06-13
In a National Institutes of Health (NIH) funded clinical trial, researchers at Emory have discovered that specific patterns of brain activity may indicate whether a depressed patient will or will not respond to treatment with medication or psychotherapy. The study was published June 12, 2013, in JAMA Psychiatry Online First.
The choice of medication versus psychotherapy is often based on the preference of the patient or clinician, rather than objective factors. On average, 35-40 percent of patients get well with whatever treatment they start with.
"To be ill with ...